Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19

prnasiaMay 13, 2021

Tag: APR-AOS2020 , COVID-19 , APR , HCLO

PharmaSources Customer Service